Latest Articles
SGO 2026: Ovarian OS Gains and New Endometrial Targets - Medscape
SGO 2026: Ovarian OS Gains and New Endometrial Targets Medscape
Published: April 17, 2026, 6:56 p.m.
Nivo-Ipi Breaks Resistance in Rare Ovarian Subtypes - Medscape
Nivo-Ipi Breaks Resistance in Rare Ovarian Subtypes Medscape
Published: April 17, 2026, 2:25 p.m.
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents - MedPage Today
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents MedPage Today
Published: April 16, 2026, 7:11 p.m.
REGN5668 Combo Yields Preliminary Activity in Recurrent Ovarian/Endometrial Cancer - CancerNetwork
REGN5668 Combo Yields Preliminary Activity in Recurrent Ovarian/Endometrial Cancer CancerNetwork
Published: April 14, 2026, 8:09 p.m.
GSK ovarian and womb cancer drug shows promise in early trial - FemTech World
GSK ovarian and womb cancer drug shows promise in early trial FemTech World
Published: April 13, 2026, 11:05 a.m.
GSK (NYSE: GSK) reports Mo-Rez data in ovarian, endometrial cancer - Stock Titan
GSK (NYSE: GSK) reports Mo-Rez data in ovarian, endometrial cancer Stock Titan
Published: April 13, 2026, 10:23 a.m.
Wonder drug for treating ovarian, womb cancer on the way - NewsBytes
Wonder drug for treating ovarian, womb cancer on the way NewsBytes
Published: April 13, 2026, 6:21 a.m.
GSK posts encouraging data for endometrial and ovarian cancer drug - London South East
GSK posts encouraging data for endometrial and ovarian cancer drug London South East
Published: April 13, 2026, 6 a.m.
GSK reports promising early results in ovarian and womb cancer drug trial - The Guardian
GSK reports promising early results in ovarian and womb cancer drug trial The Guardian
Published: April 12, 2026, 10:52 p.m.
SYS6043 Shows Initial Antitumor Activity in Pretreated Ovarian, Endometrial, and Cervical Cancer - OncLive
SYS6043 Shows Initial Antitumor Activity in Pretreated Ovarian, Endometrial, and Cervical Cancer OncLive
Published: April 12, 2026, 9:35 p.m.
Link copied to clipboard!